Seclidemstat is an investigational new drug that is being evaluated for the treatment of cancer. It is a small-molecule inhibitor of lysine-specific demethylase 1 (LSD1, KDM1A).
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.